National summit calls for urgent action, multistakeholder collaboration to bridge cancer care gaps

Cancer is now the second leading cause of death in the country, with 153,751 new cases and 254 deaths reported every day. Breast, lung and colorectal cancers are the top three in terms of incidence while lung cancer ranks number 1 in mortality.

DIANNE MEDINA SHARES MOTHER’S CANCER PATIENT STORY IN THE KALAYAAN NG KABABAIHAN MULA SA KANSER EVENT ADVOCATING FOR WOMEN’S CANCER PATIENTS, CARERS, AND SURVIVORS

She then made the call that women should be fearless in learning about their breast cancer condition – from being diligent with their breast self-exams to being proactive with their doctors in finding out whether they have a higher risk of getting this disease.

Increasing Accessibility to Integrated Cancer Care in Central Luzon, Philippines

Central Luzon Integrated Oncology Centre (CLIOC) said today that integrated cancer care is key to a smooth patient care journey especially in the Philippines where quality treatments can be scattered across the large country.

MSD’s Hope From Within underscores importance of early diagnosis in its second “Tita Hope Talks”

Hosted by broadcast journalist and health advocate Niña Corpuz, ‘Tita Hope Talks’ gathers experts and health stakeholders to discuss their perspective and provides their insights on various issues surrounding cancer care.

MSD’s advocacy campaign Hope From Within spearheads cancer conversation series; calls for better access to cancer care

The impact of COVID-19 pandemic on the global healthcare sector is immense. People are devouring all available information and realigning household expenses to protect themselves from the disease.

Cancer survey reveals new insights into public perception of cancer

TWO OUT OF FIVE Filipinos have been touched by cancer—either through a personal diagnosis—or by a family member, friend, or colleague diagnosed with the disease, according to a recent cancer survey commissioned by MSD in the Philippines and conducted by health technology and clinical research firm IQVIA.